CME GROUP INC. CME

CME Group highlighted several successful product launches and expansions, including Solana and XRP futures, credit futures, 1-ounce gold futures, and agricultural weekly options, all of which saw record volumes in Q3. The FX Spot+ platform, launched earlier this year, set new volume records monthly, and BrokerTec Chicago, launched two weeks prior to the call, enables side-by-side trading of futures and cash products. The company also announced an extension of its cross-margin agreement with DTCC and its FTSE Russell Index derivatives license through 2037, ensuring continuity and efficiency for clients.

Management discussed its evolving retail strategy, emphasizing distribution and efficiencies. The partnership with FanDuel aims to provide CME products to 13 million potential accounts. While the company is operationally ready to list sports events on its DCM, it awaits federal government approval to classify these as swaps rather than gaming. Management expressed caution regarding political prediction markets, viewing some as potentially manipulable and against the Commodity Exchange Act.

CME Group plans to offer 24/7 trading of cryptocurrency futures and options starting early next year, leveraging its Google Cloud transformation. The company's partnership with Google on tokenized cash is progressing, with a go-live target in 2026, which will enable value transfer outside traditional banking hours and support risk management. While prepared for 24/7 trading in other asset classes, management noted a lack of significant client demand and the associated costs for FCMs and other entities.

The launch of BrokerTec Chicago on October 6 was described as successful, with over $1 billion notional traded across all 7 cash instruments in its first 2.5 weeks. The platform saw 2-sided markets and 66% of volume traded at price points not available on the BrokerTec New York Club. This initiative aims to enhance the cash franchise by sitting cash fixed income markets side-by-side with core futures and options, attracting new clients and growing the futures franchise.

The company received approximately $1.5 billion in proceeds from the OSTTRA sale. Management indicated that a recommendation for capital deployment would be brought to the Board shortly, emphasizing CME Group's low debt-to-EBITDA ratio and disciplined approach to growth through organic means, JVs, and partnerships rather than large acquisitions. The company also highlighted its continued strong cost discipline, leading to a reduction in full-year adjusted operating expense guidance.

Market data revenue achieved its 30th consecutive quarter of growth, reaching a record $203 million, up 14% year-over-year. This growth was attributed to increased subscribers across professional and non-professional segments, particularly overseas in APAC and EMEA. CME Group announced a 3.5% price increase for many of its data products, effective January 1, 2026, reflecting the value and demand for its market data.

Discussion around credit futures highlighted strong growth and record open interest, with 300 sales opportunities in the pipeline. Management noted the significant size of the U.S. corporate and government debt markets, totaling $37.5 trillion to $38 trillion, creating an interesting dynamic for participation in credit markets. The company sees active engagement in both cash U.S. treasury and corporate credit markets in the coming years.